Heartseed Inc. (TYO:219A)

Japan flag Japan · Delayed Price · Currency is JPY
1,833.00
+16.00 (0.88%)
Apr 28, 2026, 3:30 PM JST
-13.70%
Market Cap 41.93B
Revenue (ttm) 3.03B
Net Income (ttm) 592.50M
Shares Out 22.87M
EPS (ttm) 25.71
PE Ratio 71.30
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 142,400
Average Volume 186,920
Open 1,808.00
Previous Close 1,817.00
Day's Range 1,803.00 - 1,833.00
52-Week Range 1,343.00 - 4,385.00
Beta n/a
RSI 46.40
Earnings Date Jun 12, 2026

About Heartseed

Heartseed Inc. develops and commercializes iPS cell-derived cardiomyocyte replacement therapy for heart failure. The company’s lead product is HS-001 for heart failure with reduced ejection fraction indications, including dilated cardiomyopathy, old myocardial infraction, and dilated phase of hypertrophic cardiomyopathy. It also develops products using autologous iPSC and HLA knock-out iPSC. In addition, the company offers differentiation induction, mass culture, purification, and myocardial globule production technology. The company was incorp... [Read more]

Industry Medical - Pharmaceuticals
Sector Healthcare
Founded 2015
Country Japan
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 219A
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.